Minor differences in the molecular machinery mediating regulated membrane fusion has major impact on metabolic health.
The exocytosis of signaling molecules from neuronal, neuroendocrine and endocrine cells is regulated by membrane fusion involving SNAP-25 and associated SNARE proteins. The importance of this process for metabolic control recently became evident by studies of mouse mutants genetically engineered to only express one of 2 closely related, alternatively-spliced variants of SNAP-25. The results showed that even minor differences in the function of proteins regulating exocytosis are sufficient to provoke metabolic disease, including hyperglycaemia, liver steatosis, adipocyte hypertrophy and obesity. Thus, an imbalance in the dynamics of hormonal and/or neurotransmitter release can cause obesity and type 2 diabetes. This recent discovery highlights the fact that metabolic health requires a perfectly operating interplay between the SNARE protein machinery in excitable cells and the organs responding to these messengers.
Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden.
Ismael
I
Valladolid-Acebes
Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden.
Teresa
T
Daraio
Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden.
Kerstin
K
Brismar
Department of Neuroscience, Karolinska Institutet , Stockholm, Sweden.
Tomas
T
Hökfelt
Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden.
Christina
C
Bark
SNARE; alternative splicing; hormones; insulin; regulated membrane fusion